Apheresis Equipment Market Size, Trends, Share, Growth | Report 2023-2032
The global apheresis equipment market was valued at USD 2.70 billion in 2022 and it is predicted to surpass around USD 7.65 billion by 2032 with a CAGR of 10.98% from 2023 to 2032.
Key Pointers
The rising prevalence of blood-related disorders and the availability of favorable government initiatives along with reimbursement frameworks are expected to drive the market growth. Further, the rising popularity and participation in blood donation drives and camps along with the growing number of blood transfusions are anticipated to support the demand for apheresis equipment during the forecast period.
The rising prevalence of chronic diseases such as autoimmune diseases and cancer is anticipated to boost the market growth. According to National Stem Cell Foundation (NSCF), approximately 4% of the world's population suffers from one of over 80 different autoimmune diseases. Autoimmune diseases are the third leading cause of chronic disease in the U.S.For instance, according to Johns Hopkins Medicine Pathology, all autoimmune diseases together affect about 3% of the U.S. population, which is about 10 million people. Therapeutic plasma exchange (TPE) is widely used for the treatment of autoimmune diseases.
The rise in the number of platelet donors and R&D investments by biopharmaceutical companies are expected to bode well with the market. According to the Centers for Disease Control and Prevention, hemophilia A affects around one in every 5,000 male births. Around 400 babies are born with hemophilia every year.
The growing demand for the different components of the blood, and the raising complex surgical approaches are increasing the demand for apheresis equipment. As per The American National Red Cross, around 29,000 units of RBCs are needed daily in the U.S. Approximately 16 million blood components are transfused each year. However, the market's expansion is being hampered by risk with apheresis devices, as well as a lack of donor availability and histocompatibility.
Apheresis Equipment Market Segmentations:
| By Product | By Application | By Procedure | By Technology |
|
Disposable Apheresis Kits Device |
Renal Diseases Haematology Neurology Others |
Plasmapheresis LDL apheresis Plateletpheresis Leukapheresis Photopheresis Erythrocytapheresis Others |
Membrane Filtration Centrifugation |
Apheresis Equipment Market Key Players and Regions Segmentations:
| Key Players | Regions |
|
B. Braun Melsungen AG Haemonetics Corporation Fresenius KabiAG Asahi Kasei Medical Co., Ltd. Terumo BCT, Inc. Mallinckrodt Nikkiso Europe GmbH |
North America Europe Asia Pacific Latin America Middle East & Africa |
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Apheresis Equipment Market
5.1. COVID-19 Landscape: Apheresis Equipment Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Apheresis Equipment Market, By Product
8.1. Apheresis Equipment Market, by Product, 2023-2032
8.1.1. Disposable Apheresis Kits
8.1.1.1. Market Revenue and Forecast (2019-2032)
8.1.2. Device
8.1.2.1. Market Revenue and Forecast (2019-2032)
Chapter 9. Global Apheresis Equipment Market, By Application
9.1. Apheresis Equipment Market, by Application, 2023-2032
9.1.1. Renal Diseases
9.1.1.1. Market Revenue and Forecast (2019-2032)
9.1.2. Haematology
9.1.2.1. Market Revenue and Forecast (2019-2032)
9.1.3. Neurology
9.1.3.1. Market Revenue and Forecast (2019-2032)
9.1.4. Others
9.1.4.1. Market Revenue and Forecast (2019-2032)
Chapter 10. Global Apheresis Equipment Market, By Procedure
10.1. Apheresis Equipment Market, by Procedure, 2023-2032
10.1.1. Plasmapheresis
10.1.1.1. Market Revenue and Forecast (2019-2032)
10.1.2. LDL apheresis
10.1.2.1. Market Revenue and Forecast (2019-2032)
10.1.3. Plateletpheresis
10.1.3.1. Market Revenue and Forecast (2019-2032)
10.1.4. Leukapheresis
10.1.4.1. Market Revenue and Forecast (2019-2032)
10.1.5. Photopheresis
10.1.5.1. Market Revenue and Forecast (2019-2032)
10.1.6. Erythrocytapheresis
10.1.6.1. Market Revenue and Forecast (2019-2032)
10.1.6. Others
10.1.6.1. Market Revenue and Forecast (2019-2032)
Chapter 11. Global Apheresis Equipment Market, By Technology
11.1. Apheresis Equipment Market, by Technology, 2023-2032
11.1.1. Membrane Filtration
11.1.1.1. Market Revenue and Forecast (2019-2032)
11.1.2. Centrifugation
11.1.2.1. Market Revenue and Forecast (2019-2032)
Chapter 12. Global Apheresis Equipment Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Product (2019-2032)
12.1.2. Market Revenue and Forecast, by Application (2019-2032)
12.1.3. Market Revenue and Forecast, by Procedure (2019-2032)
12.1.4. Market Revenue and Forecast, by Technology (2019-2032)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Product (2019-2032)
12.1.5.2. Market Revenue and Forecast, by Application (2019-2032)
12.1.5.3. Market Revenue and Forecast, by Procedure (2019-2032)
12.1.5.4. Market Revenue and Forecast, by Technology (2019-2032)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Product (2019-2032)
12.1.6.2. Market Revenue and Forecast, by Application (2019-2032)
12.1.6.3. Market Revenue and Forecast, by Procedure (2019-2032)
12.1.6.4. Market Revenue and Forecast, by Technology (2019-2032)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Product (2019-2032)
12.2.2. Market Revenue and Forecast, by Application (2019-2032)
12.2.3. Market Revenue and Forecast, by Procedure (2019-2032)
12.2.4. Market Revenue and Forecast, by Technology (2019-2032)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Product (2019-2032)
12.2.5.2. Market Revenue and Forecast, by Application (2019-2032)
12.2.5.3. Market Revenue and Forecast, by Procedure (2019-2032)
12.2.5.4. Market Revenue and Forecast, by Technology (2019-2032)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Product (2019-2032)
12.2.6.2. Market Revenue and Forecast, by Application (2019-2032)
12.2.6.3. Market Revenue and Forecast, by Procedure (2019-2032)
12.2.6.4. Market Revenue and Forecast, by Technology (2019-2032)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Product (2019-2032)
12.2.7.2. Market Revenue and Forecast, by Application (2019-2032)
12.2.7.3. Market Revenue and Forecast, by Procedure (2019-2032)
12.2.7.4. Market Revenue and Forecast, by Technology (2019-2032)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Product (2019-2032)
12.2.8.2. Market Revenue and Forecast, by Application (2019-2032)
12.2.8.3. Market Revenue and Forecast, by Procedure (2019-2032)
12.2.8.4. Market Revenue and Forecast, by Technology (2019-2032)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Product (2019-2032)
12.3.2. Market Revenue and Forecast, by Application (2019-2032)
12.3.3. Market Revenue and Forecast, by Procedure (2019-2032)
12.3.4. Market Revenue and Forecast, by Technology (2019-2032)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Product (2019-2032)
12.3.5.2. Market Revenue and Forecast, by Application (2019-2032)
12.3.5.3. Market Revenue and Forecast, by Procedure (2019-2032)
12.3.5.4. Market Revenue and Forecast, by Technology (2019-2032)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Product (2019-2032)
12.3.6.2. Market Revenue and Forecast, by Application (2019-2032)
12.3.6.3. Market Revenue and Forecast, by Procedure (2019-2032)
12.3.6.4. Market Revenue and Forecast, by Technology (2019-2032)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Product (2019-2032)
12.3.7.2. Market Revenue and Forecast, by Application (2019-2032)
12.3.7.3. Market Revenue and Forecast, by Procedure (2019-2032)
12.3.7.4. Market Revenue and Forecast, by Technology (2019-2032)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Product (2019-2032)
12.3.8.2. Market Revenue and Forecast, by Application (2019-2032)
12.3.8.3. Market Revenue and Forecast, by Procedure (2019-2032)
12.3.8.4. Market Revenue and Forecast, by Technology (2019-2032)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Product (2019-2032)
12.4.2. Market Revenue and Forecast, by Application (2019-2032)
12.4.3. Market Revenue and Forecast, by Procedure (2019-2032)
12.4.4. Market Revenue and Forecast, by Technology (2019-2032)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Product (2019-2032)
12.4.5.2. Market Revenue and Forecast, by Application (2019-2032)
12.4.5.3. Market Revenue and Forecast, by Procedure (2019-2032)
12.4.5.4. Market Revenue and Forecast, by Technology (2019-2032)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Product (2019-2032)
12.4.6.2. Market Revenue and Forecast, by Application (2019-2032)
12.4.6.3. Market Revenue and Forecast, by Procedure (2019-2032)
12.4.6.4. Market Revenue and Forecast, by Technology (2019-2032)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Product (2019-2032)
12.4.7.2. Market Revenue and Forecast, by Application (2019-2032)
12.4.7.3. Market Revenue and Forecast, by Procedure (2019-2032)
12.4.7.4. Market Revenue and Forecast, by Technology (2019-2032)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Product (2019-2032)
12.4.8.2. Market Revenue and Forecast, by Application (2019-2032)
12.4.8.3. Market Revenue and Forecast, by Procedure (2019-2032)
12.4.8.4. Market Revenue and Forecast, by Technology (2019-2032)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Product (2019-2032)
12.5.2. Market Revenue and Forecast, by Application (2019-2032)
12.5.3. Market Revenue and Forecast, by Procedure (2019-2032)
12.5.4. Market Revenue and Forecast, by Technology (2019-2032)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Product (2019-2032)
12.5.5.2. Market Revenue and Forecast, by Application (2019-2032)
12.5.5.3. Market Revenue and Forecast, by Procedure (2019-2032)
12.5.5.4. Market Revenue and Forecast, by Technology (2019-2032)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Product (2019-2032)
12.5.6.2. Market Revenue and Forecast, by Application (2019-2032)
12.5.6.3. Market Revenue and Forecast, by Procedure (2019-2032)
12.5.6.4. Market Revenue and Forecast, by Technology (2019-2032)
Chapter 13. Company Profiles
13.1. B. Braun Melsungen AG
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Haemonetics Corporation
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Fresenius KabiAG
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Asahi Kasei Medical Co., Ltd.
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Terumo BCT, Inc.
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Mallinckrodt
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Nikkiso Europe GmbH
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers